Chenlu Li

Title: Chenlu Li: Innovator in Pharmaceutical Chemistry

Introduction

Chenlu Li is a prominent inventor based in Dongguan, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on thienopyrimidine derivatives. His research focuses on the development of compounds that can be utilized in medical applications.

Latest Patents

Chenlu Li holds a patent for a thienopyrimidine derivative and its use in medicine. This invention relates to a pharmaceutical composition that contains the compound, which is specifically designed to inhibit acetyl-CoA carboxylase (ACC). The compound and its pharmaceutical composition are intended for the treatment or prevention of diseases regulated by ACC in mammals, especially in humans.

Career Highlights

Throughout his career, Chenlu Li has demonstrated a strong commitment to advancing medical science through his innovative research. His work has led to the development of valuable pharmaceutical compounds that have the potential to improve health outcomes.

Collaborations

Chenlu Li has collaborated with notable colleagues, including Wanjun Tang and Xinye Yang. These partnerships have contributed to the success of his research and the advancement of their shared goals in pharmaceutical development.

Conclusion

In summary, Chenlu Li is a dedicated inventor whose work in pharmaceutical chemistry has led to significant advancements in medical treatments. His innovative approach to developing thienopyrimidine derivatives showcases his commitment to improving healthcare through scientific research.